 dose, the relative safety and efficacy of different thrombolytic agents and mechanical thrombectomy devices, and
the appropriate intensity of anticoagulation to be used
during thrombolytic procedures. Also, too little data are
available to guide recommendations regarding the use of
adjuvants such as intermittent pneumatic compression.106,107 Finally, the quality-of-life benefits and costeffectiveness of this therapy need to be more thoroughly
evaluated.
AUTH